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Background: Exposure to perinatal anxiety affects disease susceptibility in offspring but studies on the association
between perinatal anxiety and gene polymorphisms are lacking. This study aimed to elucidate the interaction
between perinatal anxiety and polymorphisms in antioxidant defense and innate immunity genes on the
development of respiratory tract infections (RTIs) during early infancy.
Methods: Trait anxiety levels in 440 women were assessed by the State-Trait Anxiety Inventory during late gestation.
The occurrence of RTIs, including bronchiolitis, during the first year of life was assessed by parent-reported doctor
diagnosis. Polymorphisms in glutathione S-transferase P-1 (GSTP1, rs1695) and CD14 (rs2569190) were genotyped using
the TaqMan assay. Copy number variations of GSTT1 were measured by real-time polymerase chain reaction.
Results: Exposure to high levels of perinatal anxiety increased the risk of bronchiolitis in the first year of life (adjusted
odds ratio [aOR], 1.30; 95% confidence interval [CI]: 1.00–1.80), in particular among children with the AG + GG genotype
of GSTP1 or the GSTT1 null genotype (aOR 3.36 and 2.79). In infants with the TC + CC genotype of CD14, high levels of
perinatal anxiety were associated with an increased risk of upper RTI, lower RTI, and bronchiolitis (aOR 2.51, 4.60, and
4.31, respectively).
Conclusions: Perinatal maternal anxiety levels affect the occurrence of bronchiolitis in offspring. The effect of perinatal
anxiety on the occurrence of bronchiolitis during infancy was influenced by genetic polymorphisms in antioxidant
defense and innate immunity genes.
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Environmental factors during early life influence the
development of the immune system and physiology, and
change susceptibility to disease in later life [1]. Recent
studies reveal that perinatal maternal stress and anxiety
affect susceptibility to infectious diseases in later life
[2]. Respiratory tract infections (RTIs) account for the* Correspondence: yjshin@yuhs.ac; sjhong@amc.seoul.kr
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unless otherwise stated.majority of morbidity and mortality during infancy and
thus pose a worldwide burden that can be prevented by
the modification of environmental factors [3,4].
The mechanisms underlying the associations between
exposure to perinatal maternal anxiety and an increased
risk of RTIs are not fully elucidated. Perinatal maternal
anxiety increases glucocorticoids in pregnant women,
which can cross the placental barrier. This may affect
fetal programming through immunomodulation [5],
and perinatal anxiety may cause epigenetic changes in
the offspring leading to an increased vulnerability to
neurodevelopmental diseases in later life [6]. However,
no study has directly demonstrated the possible mecha-
nisms underlying the association between exposure to. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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offspring.
Perinatal anxiety and RTIs share a common pathway
of oxidative stress [7,8]. Exposure to perinatal anxiety
increases the serum levels of glucocorticoids in offspring
[9], generating higher levels of reactive oxygen species
(ROS). During RTIs, high levels of ROS are generated in
the epithelium of the respiratory tract. This increased
oxidative stress is associated with alterations in the
immune response and affects fetal programming [10,11].
The glutathione S-transferase (GST) subfamily plays
an important role in the protection against oxidative
stress by catalyzing the conjugation of many compounds
with reduced glutathione [12]. Polymorphisms in the
GST genes, GSTP1 (rs1695) and GSTT1, affect the ability
to deal with excessive oxidative stress due to the resultant
altered activity of the GST enzymes [12]. In subjects with
the AG+GG genotype of GSTP1 (rs1695), the enzymatic
activity of GSTP1 is partially reduced, compared to
subjects with the AA genotype [12]. The null genotype
of GSTT1 is associated with an absence of enzyme
activity [12]. CD14 is essential for host defense because
it acts as a receptor for microbial ligands during the
innate immune response [13]. A functional polymorphism
of CD14 (rs2569190) is associated with an enhanced
immune response, and thereby affects the risk of RTIs
[14,15]. This suggests that these genetic variants may
affect the occurrence of RTIs and environmental factors
may exaggerate the effects of these genetic variations.
Therefore, we hypothesized that there are associations
between exposure to perinatal anxiety and genetic variants
involved in antioxidant defense and innate immunity, and
these interactions influence the RTI risk in offspring,
especially during early life. The first aim of this study
was to examine the association between perinatal anxiety
and RTI occurrence during the first year of life. Second,
the effect of the interaction between exposure to perinatal
anxiety and genetic variants of some GST subfamily
genes and CD14 (rs2569190) on the occurrence of RTIs
was explored.
Methods
Participants
Data was used from the COhort for Childhood Origin of
Asthma and allergic disease (COCOA), a prospective
birth cohort study that aimed to investigate the effects
of environmental and genetic factors during early life on
the development of allergic diseases and children’s health
[16-18]. Women in the third trimester of pregnancy
were enrolled from January 2009 to September 2011.
The questionnaire used in this study included items on
the State-Trait Anxiety Inventory (STAI). Pregnant women
with pregnancy-associated complications (gestational dia-
betes and pregnancy-induced hypertension), high risk forearly delivery, and delivery earlier than 36 weeks have been
excluded. Neonates were excluded if they needed oxygen
therapy, or had congenital anomalies including congenital
diaphragmatic hernia, congenital heart disease, congenital
lung diseases, or severe systemic diseases. More details on
this cohort study are described elsewhere [19].
Among 734 eligible women, 71 refused to participate,
4 were lost to follow up, and 28 were excluded due to
preterm delivery. Among a total of 631 (86%), 440 (69.7%)
completed the STAI questionnaire. Study participants did
not differ from those women not included in the study
with regard to key demographic covariates, except for
the season of offspring’s birth (Table 1). Information on
potential confounders was obtained from a parental-
reported questionnaire at the 36th week of pregnancy
and medical records at the child’s birth. Questionnaires
assessed maternal health problems including allergic
diseases (atopic dermatitis, allergic rhinitis, or asthma),
socioeconomic status (income and educational levels), and
prenatal environmental factors such as tobacco smoking
exposure at 36 weeks of gestation. The newborn’s sex
and weight, gestational age, season of birth, and health
conditions were obtained by a questionnaire after birth.
Written informed consent was obtained from all women
and the study was approved by Asan Medical Center
(IRB No. 2008-0616), Samsung Medical Center (IRB No.
2009-02-021), Yonsei University (IRB No. 4-2008-0588),
and CHA Medical Center (IRB No. 2010-010).Anxiety assessment
Data on perinatal maternal anxiety were obtained by
self-report at the 36th week of pregnancy. Instead of using
STAI, the Korean version of STAI (K-STAI) was used,
which consists of two subscales, namely State Anxiety
(anxiety about an event) and Trait Anxiety (anxiety levels
as a personal characteristic). The Trait Anxiety subscale
(STAI-T) was used in this study because it reflects the
baseline anxiety levels of the subjects rather than a transi-
ent anxiety state. STAI-T is a 20 item questionnaire scored
on a four-point Likert-type scale that measures a general
tendency to be anxious [20]. Scores range from 20 to 80,
with a higher score indicating a more severe anxiety level.
K-STAI exhibits excellent psychometric properties [21]
and its internal consistency has been reported as having
a Cronbach’s α coefficient of 0.91 [22]. In this study, the
reliability coefficient (Cronbach’s α) of STAI-T was 0.92.Assessment of 1 year outcome variables
The infants were examined at 1 year of age with at least
one parent present at follow-up visits. RTIs were assessed
by parent-reported doctor diagnosis during the first year
of life. RTIs were further categorized as upper (URTIs)
and lower (LRTIs) RTIs. URTIs included common colds,
Table 1 Characteristics of the study population and subjects not included in the current analysis
Women included in this study Women not included in this study P-value
n Mean ± SD or n (%) n Mean ± SD or n (%)
Covariates (mother) 440 193
Maternal age (years) 32.5 ± 3.55 32.4 ± 3.45 0.736
BMI (kg/m2) 20.7 ± 2.67 20.7 ± 2.60 0.754
Maternal educational level
Secondary school 31 (7.0%) 21 (10.9%) 0.202
College or University 289 (65.7%) 116 (60.1%)
Graduate school 120 (27.3%) 56 (29.0%)
Environmental tobacco exposure 265 (60.8%) 105 (54.4%) 0.171
History of any allergic disorder (AD, AR, Asthma) 124 (28.2%) 59 (30.7%) 0.568
Covariates (father) 410
History of any allergic disorder (AD, AR, Asthma) 115 (26.1%) 51 (26.4%) 0.939
Covariates (infant) 440 193
Sex: Girl 217 (49.3%) 85 (44.2%) 0.227
Birth weight (g) 3143.9 ± 422.01 3198.3 ± 395.43 0.153
Season of birth
Spring 117 (26.6%) 28 (14.5%) < 0.001
Summer 117 (26.6%) 26 (13.5%)
Autumn 96 (21.8%) 91 (47.2%)
Winter 110 (25.0%) 48 (24.9%)
Mode of delivery: Caesarean section 134 (34.4%) 68 (35.2%) 0.793
Gestational age (months) 39.2 ± 1.08 39.2 ± 1.09 0.968
Presence of siblings 198 (45.0%) 83 (43.0%) 0.705
Daycare attendance during the first year of life 105 (23.9%) 43 (22.3%) 0.740
Exposure to perinatal maternal anxiety 440 N/A
STAI score 41.0 ± 8.47 (20–71)
Physician diagnosed respiratory tract infection during the first year of life
Upper respiratory tract infection 337 (76.6%)
Lower respiratory tract infection 65 (14.8%)
Bronchiolitis 48 (10.9%)
AD, atopic dermatitis; AR, allergic rhinitis; N/A, not applicable; STAI, State-Trait Anxiety Inventory.
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monia, tracheobronchitis, and bronchiolitis.
DNA isolation and genotyping
Genomic DNA was extracted from the buffy coat of the
cord blood at delivery using the Gentra® Puregene®
Blood kit (Qiagen, Maryland, USA), as recommended by
the manufacturer. Genotyping of CD14 (rs2569190) and
GSTP1 (rs1695) was conducted using a TaqMan assay
(ABI, Foster City, CA, USA). Assay identification num-
bers for CD14 and GSTP1 were C_16043997_10 and
C_3237198_20, respectively. Copy number variations
(CNV) of GSTM1 and GSTT1 were measured by real-
time polymerase chain reaction (RT-PCR). The primers
and probe for GSTM1 and GSTT1 were synthesizedaccording to Brasch-Andersen C et al. [23]. Reactions
were performed as a triplex, with RNAse P as the refer-
ence gene. The allele frequencies of the polymorphisms in
GSTP1 (rs1695), GSTM1, GSTT1, and CD14 (rs2569190)
were in Hardy-Weinberg equilibrium (P > 0.1).
Statistical analysis
The association between perinatal maternal anxiety levels
and RTIs (URTIs, LRTIs, and bronchiolitis) during the first
year of life was examined using logistic regression. Adjust-
ments were made for baseline demographic factors (child’s
sex and maternal age) as well as known risk factors for
respiratory infections, including maternal educational level,
exposure to tobacco smoking during the first year, and
presence of maternal and paternal allergic diseases [24,25].
Table 2 Odds ratio and 95% confidence interval for
perinatal anxiety predicting RTIs at age 1 year
Exposure Outcome Unadjusted Adjusted*
OR† 95% CI OR 95% CI
STAI (SD) URTI 1.04 (0.84–1.30) 1.10 (0.87–1.39)
LRTI 1.31‡ (1.01–1.71) 1.35‡ (1.01–1.78)
Bronchiolitis 1.35‡ (1.00–1.81) 1.30§ (1.00–1.80)
CI, confidence interval; OR, odds ratio; RTI, respiratory tract infection;
SD, standard deviation; STAI, State-Trait Anxiety Inventory.
*Adjusted for child’s sex, season of birth, maternal age, education level,
exposure to tobacco smoking during the first year of life, history of maternal
allergic diseases and history of any paternal allergic diseases (atopic
dermatitis, allergic rhinitis, or asthma).
†Logistic regression models were used to calculate OR and 95% CI.
‡p-value < 0.05.
§p-value < 0.10.
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regression analyses was 8.47. Parameter estimates were
multiplied by the SD of the STAI score, and for 95%
confidence interval (CI), the following equation was
used: BETA*(SD of STAI score) ± 1.96*SE*(SD of STAI
score). In logistic regression analysis, the estimates were
exponentiated to obtain the estimate and 95% CI of the
odds ratio (OR).
The combined effects of perinatal anxiety and genetic
polymorphisms on RTI risk were investigated by multi-
variate logistic regression analysis. To analyze the com-
bined effect of the two factors, STAI scores were divided
into two categories on the basis of mean levels and
genetic polymorphisms were classified according to
GSTT1 null or present, GSTM1 null or present, and
polymorphisms of GSTP1 (rs1695) and CD14 (rs2569190).
All statistical analyses were performed using SAS for
Windows (version 9.2).
Results
Demographics
Table 1 summarizes the descriptive statistics across the
total sample. There were no significant differences in
maternal age, maternal education level, infants’ sex, mode
of delivery, presence of infants’ siblings, and daycare
attendance of infants between pregnant women included
in this study and those excluded. Overall, the mean mater-
nal age was 32.5 years. Exposure to tobacco smoking
during pregnancy was reported by 60.8% of the women.
In mothers, 28.2% had a history of allergic disease,
whereas in spouses the proportion was 26.1%. The STAI
score demonstrated a normal distribution with mean ± SD
of 41.0 ± 8.47. Approximately half (49.3%) of the offspring
were girls, with a mean gestational age of 39.2 weeks.
Births were evenly distributed between the four seasons
(26.6% in spring, 26.6% in summer, 21.8% in autumn, and
25.0% in winter). Approximately one third of births
(34.4%) were delivered by caesarean section.
Association between perinatal maternal anxiety and
development of RTIs during the first year of life
High levels of perinatal maternal anxiety were associated
with an increased risk of LRTIs, especially bronchiolitis,
but not with total URTIs (Table 2). For a 1 SD increase
in STAI score, the odds of LRTI risk during the first year
of life increased by 1.35 times (95% CI: 1.01–1.78). The
crude association between perinatal anxiety levels and
the development of bronchiolitis was weakly significant
(OR 1.35, 95% CI: 1.00–1.81; adjusted OR [aOR] 1.30,
95% CI: 1.00–1.80). However, perinatal anxiety did not
increase the risk of URTIs (aOR 1.10, 95% CI: 0.87–1.39).
In addition, high levels of perinatal maternal anxiety were
not significantly associated with the occurrence of other
subtypes of RTIs except bronchiolitis. Figure 1 representsthe predicted probability of bronchiolitis at 1 year of age
for each observed value of perinatal anxiety score in the
multivariate model.
Combined effect between perinatal maternal anxiety
levels and GSTP1 (rs1695), GSTT1, GSTM1 polymorphisms
on the development of RTIs during the first year of life
Genetic polymorphisms in GSTP1 (rs1695), GSTT1 or
GSTM1 did not increase the risk of any types of RTIs
(data not shown). Exposure to high levels of perinatal
anxiety was associated with an increased risk for LRTIs,
especially bronchiolitis, in infants with the AG +GG
genotype of GSTP1 (rs1695), compared to infants with
exposure to low levels of perinatal anxiety and with the
AA genotype (aOR 2.61, 95% CI: 1.09–6.22; aOR 3.36,
95% CI: 1.25–9.03, respectively) (Table 3). Analysis of
the three genotypes showed that, infants with the GG
genotype of GSTP1 (rs1695) had a significantly increased
risk of LRTIs, especially bronchiolitis, during the first year
of life (aOR 22.04, 95% CI: 4.79–101.47; aOR 14.61, 95%
CI: 3.23–66.11, respectively) (Additional file 1: Figure S1).
In addition, infants with both the GSTT1-null geno-
type and exposure to high levels of perinatal anxiety
were associated with an increased risk for LRTIs, espe-
cially bronchiolitis, compared to infants with both the
GSTT1-present genotype and exposure to low levels of
perinatal anxiety (aOR 2.47, 95% CI: 1.04–5.89; aOR
2.79, 95% CI: 1.05–7.43) (Table 4). In terms of GSTM1,
exposure to high levels of perinatal anxiety increased the
risk of LRTIs during the first year of life, regardless of
the genotypes (present genotype: aOR 2.95, 95% CI:
1.06–8.17; null genotype: aOR 2.60, 95% CI: 1.01–6.66)
(Additional file 2: Table S1).
Combined effect between exposure to perinatal maternal
anxiety and CD14 (rs2569190) polymorphism on the
development of RTIs during the first year of life
Infants with the TT genotype of CD14 (rs2569190) had an
increased risk of URTIs and LRTIs, especially bronchiolitis,
Figure 1 Relationship between perinatal maternal anxiety levels and predicted probability of bronchiolitis at 1 year of age.
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compared with infants exposed to low levels of perinatal
anxiety (aOR 2.51, 95% CI: 1.01–6.24; aOR 4.60, 95% CI:
1.29–16.41; aOR 4.31, 95% CI: 1.17–15.79, respectively)
(Additional file 3: Table S2).
Discussion
Main findings
In this study, a positive association was found between
exposure to high levels of perinatal anxiety and develop-
ment of RTIs in offspring during the first year of life.Table 3 Interactions between maternal perinatal anxiety (STA
development of respiratory tract infection during the first ye
URTI*
STAI GSTP1 URTI
diagnosis (-)
URTI
diagnosis (+)
aOR‡
(95% CI)
LRTI
diagnosis
low (≤41) AA 36 111 1 133
low (≤41) AG + GG 17 43 1.10
(0.53–2.27)
51
high (>41) AA 31 90 1.25
(0.68–2.30)
101
high (>41) AG + GG 13 53 1.91
(0.86–4.25)
52
aOR, adjusted odds ratio; CI, confidence interval; GSTP1, glutathione S-transferase P
URTI, upper respiratory tract infection; STAI, State-Trait Anxiety Inventory.
*URTI includes common colds, sinusitis, otitis media, and croup.
†LRTI includes pneumonia, tracheobronchitis, and bronchiolitis.
‡Adjusted for infant’s sex, season of birth, maternal age, education level, prenatal ex
history of any paternal allergic diseases (atopic dermatitis, allergic rhinitis, or asthmThe risk of LRTIs, especially bronchiolitis, during early
infancy was influenced by additive effects between exposure
to perinatal anxiety and polymorphisms in antioxidant-
related genes. To the best of our knowledge, this is the first
study examining the gene-environment interactions with
respect to perinatal anxiety on the development of RTIs
during early life.
Exposure to high levels of perinatal anxiety affected the
development of RTIs, especially bronchiolitis, differently
during infancy, depending on the polymorphisms of ROS
detoxification genes such as GSTP1 (rs1695) and GSTT1.I score) and GSTP1 (rs1695) polymorphism on the
ar of life
LRTI† Bronchiolitis
(-)
LRTI
diagnosis (+)
aOR‡
(95% CI)
Bronchiolitis
diagnosis (-)
Bronchiolitis
diagnosis (+)
aOR‡
95% CI
14 1 138 9 1
9 1.66
(0.64–4.26)
52 8 2.14
(0.74–6.15)
20 1.99
(0.92–4.29)
106 15 2.07
(0.83–5.16)
14 2.61
(1.09–6.22)
54 12 3.36
(1.25–9.03)
1; LRTI, lower respiratory tract infection; RTI, respiratory tract infection;
posure to tobacco smoking, history of any maternal allergic diseases and
a).
Table 4 Interactions between maternal perinatal anxiety (STAI score) and copy number variation of GSTT1 on the development of respiratory tract infection
during the first year of life
URTI* LRTI† Bronchiolitis
STAI GSTT1 URTI diagnosis
(-), n
URTI diagnosis
(+), n
aOR‡
(95% CI)
LRTI diagnosis
(-), n
LRTI diagnosis
(+), n
aOR‡
(95% CI)
Bronchiolitis
diagnosis (-), n
Bronchiolitis
diagnosis (+), n
aOR‡
(95% CI)
low (≤41) CNV≥ 1 16 76 1 82 10 1 85 7 1
low (≤41) CNV = 0 37 76 0.43 (0.21–0.88) 102 11 0.86 (0.33–2.21) 104 9 0.97 (0.33–2.83)
high (>41) CNV≥ 1 22 65 0.66 (0.30–1.45) 75 12 1.29 (0.50–3.33) 79 8 1.13 (0.37–3.34)
high (>41) CNV = 0 22 77 1.02 (0.46–2.26) 77 22 2.47 (1.04–5.89) 80 19 2.79 (1.05–7.43)
aOR, adjusted odds ratio; CI, confidence interval; CNV, copy number variation; GSTT1, glutathione S-transferase T1; LRTI, lower respiratory tract infection; RTI, respiratory tract infection; URTI, upper respiratory tract
infection; STAI, State-Trait Anxiety Inventory.
*URTI includes common colds, sinusitis, otitis media, and croup.
†LRTI includes pneumonia, tracheobronchitis, and bronchiolitis.
‡Adjusted for infant’s sex, season of birth, maternal age, education level, prenatal exposure to tobacco smoking, history of any maternal allergic diseases and history of any paternal allergic diseases (atopic dermatitis,
allergic rhinitis, or asthma).
The subject number of this analysis is different from those in Table 3 due to the failure of simultaneous genotyping of GSTP1 (rs1695) and GSTT1 in several subjects.
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anxiety and ROS detoxification gene polymorphisms on
the occurrence of LRTIs, especially bronchiolitis, may be
partially attributable to the increased ROS generation
caused by high levels of perinatal maternal anxiety.
Perinatal anxiety increases glucocorticoid levels in both
mother and fetus, and this induces superoxide production
[26]. The capacity to effectively detoxify ROS is affected
by polymorphisms of ROS detoxification genes [27,28].
The increased risk of LRTIs, especially bronchiolitis, in
infants with the AG+GG genotype of GSTP1 (rs1695) or
the GSTT1-null genotype after exposure to high levels
of perinatal anxiety may be explained by the reduced
enzymatic activity in the AG + GG genotype of GSTP1
(rs1695) and by the loss of enzymatic activity in the
GSTT1-null genotype [27,28]. Since GST subfamily genes
are expressed mainly in the respiratory tract and oxidative
stress is increased during LRTIs, especially bronchiolitis
[29], genetic variants of the GST subfamily may influence
the risk of LRTIs, especially bronchiolitis.
Possible underlying mechanisms
Psychological stress and anxiety may affect the balance
of oxidant and antioxidant states and thereby influence
an individual’s health [30,31]. In response to stress, serum
glucocorticoid levels rise to modulate the stress response
[32]. Glucocorticoid levels affect antioxidant enzyme
levels, and antioxidant enzyme activity in the lungs begins
in late gestation [33,34]. Considering the impact of ROS in
fetal programming and variants of ROS-related genes on
the capacity to detoxify ROS [11,12], the increased suscep-
tibility to RTIs in offspring exposed to perinatal anxiety
might be explained by their decreased ability to mitigate
the oxidative stress generated during RTIs [35].
An experimental study showed that prenatal maternal
stress influences epigenetic re-programming by altering
the expression of microRNAs involved in the stress
response, oxidative stress, and metabolism [6]. In addition,
prenatal anxiety-related immune and oxidative responses
cause telomere erosion, possibly increasing the risk of
infection [36,37]. On the basis of these findings, we sug-
gest that perinatal anxiety influences the susceptibility to
RTIs in offspring during critical periods in combination
with genetic variants of ROS-related genes or through
epigenetic mechanisms. Additional studies are needed
to clarify the underlying mechanisms.
Previous studies showed that the T allele of CD14-159C/
T is associated with an enhanced transcriptional activity
and increased soluble CD14 levels, which are markers of
monocyte and macrophage activation [38,39]. The positive
relationship between perinatal anxiety level and risk
of RTIs in infants with the TT genotype of CD14
(rs2569190) might be due to the essential role of CD14 as
an initiator of innate immunity against viral infectionsin the respiratory tract [14]. Alterations in cellular and
humoral immune responses caused by the interactions
between exposure to high levels of perinatal maternal
stress and genetic variants of CD14 might partially explain
these findings [40,41].
In this study, it was proposed that perinatal maternal
anxiety differentially affects the risk of RTIs depending on
their anatomic location in the respiratory tract. Increased
glucocorticoid levels during the fetal period may affect the
development and function of the lungs during early life
[42]. Differences in defense mechanisms, and the more
severe characteristics of LRTIs than URTIs, may account
for the increased risk of LRTIs [43,44]. In addition, func-
tional differences attributable to the genetic variants in
ROS-related genes may add an increased susceptibility to
LRTIs, especially bronchiolitis, in affected infants [27,41].
Hospitalization expenditures because of bronchiolitis
during infancy has increased [45]. A history of bronchiolitis
in infancy is associated with adverse respiratory outcome
such as reduced lung function and development of asthma
in later life [46,47]. With the prevention of bronchiolitis
during early life, health care costs and adverse respiratory
health can be avoided.
Potential limitations
The current study has a few limitations. First, the sample
size in this study is relatively small because this study is
an ongoing prospective birth cohort study. Although the
statistical power was weak to analyze the associations with
respect to each type of LRTI except bronchiolitis due to
the small sample size, this study indicates the importance
of the effect of perinatal maternal anxiety on the occur-
rence of RTIs during early life. Further large-scale studies
are needed to validate the association between perinatal
anxiety and LRTIs during infancy, especially bronchiolitis,
which is associated with adverse respiratory outcomes
such as asthma in later life. Second, mechanisms under-
lying the additive effects between perinatal anxiety and
variants of antioxidant defense genes on the occurrence
of LRTIs, especially bronchiolitis, were not explored.
However, previously reported findings were used to try and
explain the underlying pathophysiology. Also, only one
single nucleotide polymorphism (SNP) was analyzed for
each gene; however, this selection was based on previous
studies demonstrating an association between these SNPs
and the development of respiratory illnesses [29,34,38].
Finally, approximately 30% of the participants did not
report their anxiety status and were thus excluded from
the analysis.
Conclusion
This study suggests that exposure to perinatal maternal
anxiety is a significant risk factor for the development of
bronchiolitis in the first year of life. It indicates that
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of in utero exposure to perinatal anxiety on infant sus-
ceptibility to bronchiolitis during critical periods. In view
of the fact that bronchiolitis during early infancy is an
economic and medical burden and is associated with an
increased risk of recurrent wheezing and asthma in later
life, efforts to decrease perinatal anxiety may help prevent
bronchiolitis during infancy, especially in genetically sus-
ceptible infants.
Additional files
Additional file 1: Figure S1. Effect of GSTP1 (rs1695) polymorphisms
on respiratory tract infections (RTIs) according to perinatal maternal
anxiety levels. (A) The risk of upper RTIs (URTIs) during the first year
of life. (B) The risk of lower RTIs (LRTIs) during the first year of life.
(C) The risk of bronchiolitis during the first year of life.
Additional file 2: Table S1. Interactions between maternal perinatal
stress (STAI score) and copy number variations of GSTM1 on the
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